Cornell University's Brian Kirby and his colleagues reported on their development of a 'sticky' silicon chip known as geometrically enhanced differential immunocapture, or GEDI, in PLoS One in April. Now, Kirby tells the Cornell Chronicle, the researchers are applying this new cell-capture device to trap circulating tumor cells in blood samples from patients with metastatic cancers.
"Most cancer cells are bigger and more rigid than normal cells, so it's about tricking these cancer cells into colliding with the sticky walls," Kirby tells the Cornell Chronicle. The paper adds that the GEDI device is slated to go to clinical trial this year, and the Kirby and his colleagues "are actively working on detectors for breast, ovarian and pancreatic cancers."
HT: Fierce Health IT